These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21960323)

  • 1. Bridging for an isolated subtherapeutic INR: an evaluation of clinical practice patterns, outcomes, and costs from an anticoagulation clinic.
    Hwang JM; Taylor TN; Sharma KP; Clemente JL; Garwood CL
    J Thromb Thrombolysis; 2012 Jan; 33(1):28-37. PubMed ID: 21960323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).
    Phibbs CS; Love SR; Jacobson AK; Edson R; Su P; Uyeda L; Matchar DB;
    J Gen Intern Med; 2016 Sep; 31(9):1061-7. PubMed ID: 27234663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
    Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
    J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery.
    Harkin M; Shaddix BP; Neely SB; Peek LA; Stephens K; Barker P; McMullan L; Gormley A; Johnson PN
    Am J Health Syst Pharm; 2020 Jun; 77(13):1018-1025. PubMed ID: 32470108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin Patients With Anemia Show Trend of Out-of-Range International Normalized Ratio Frequency With Point-of-Care Testing in an Anticoagulation Clinic.
    DeRemer CE; McMichael B; Young HN
    J Pharm Pract; 2019 Oct; 32(5):499-502. PubMed ID: 29642733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
    Chitsike RS; Rodger MA; Kovacs MJ; Betancourt MT; Wells PS; Anderson DR; Chagnon I; LE Gal G; Solymoss S; Crowther MA; Perrier A; White RH; Vickars LM; Ramsay T; Kahn SR
    J Thromb Haemost; 2012 Oct; 10(10):2039-44. PubMed ID: 22846068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating time in therapeutic range for hemodialysis patients taking warfarin.
    Quinn LM; Richardson R; Cameron KJ; Battistella M
    Clin Nephrol; 2015 Feb; 83(2):80-5. PubMed ID: 25500296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.